OpiCalc Logo

OpiCalc

--- Clinical Tools

Logo
OpiCalc
ALBI Grade (Liver)ASTCT GradingATA Thyroid RiskBCLC 2022 Staging (HCC)BSA (Mosteller)Calvert FormulaCLL-IPICML ELTS ScoreCNS-IPICTCAE v5.0Deauville ScoreDIPSS-Plus (Myelofibrosis)EAU NMIBC RiskECOG Performance StatusELN 2022 Risk (AML)ELN CML MilestonesFIGO 2021 (Ovarian)FIGO 2023 (Endometrial)Fleischner 2017 GuidelinesFLIPI-2Fong Clinical Risk ScoreHCT-CI (Sorror Score)HPV/p16 OropharynxIGCCCG Risk (Testicular)IMDC (Heng) CriteriaIMWG Myeloma FrailtyIPSS-M (Molecular MDS)iRECISTISUP Grade GroupsiwCLL 2018 ResponseKarnofsky Status (KPS)Khorana ScoreLugano ClassificationLung-RADS v2022Mayo 20/2/20 (SMM)MIPI-b (Biological)MRD Assessment FrameworkmRECIST (HCC)mRENAL ScoremrTRG (Rectal MRI)MSI/MMR InterpretationNCCN Prostate RiskNCCN-IPI (DLBCL)NSCLC GPAOncotype DX RecurrenceOpioid EquianalgesicPD-L1 TPS InterpretationPERCIST 2.0Platinum-Free IntervalPREDICT v3.0R2-ISS (Revised 2)RANO 2.0RCB (Residual Cancer Burden)RECIST 1.1ROMA ScoreSAVER ScoreSedlis/Peters CriteriaSINS ScoreSLiM-CRAB CriteriaTNM 8th (Colorectal)TNM 8th Ed (Prognostic)TNM 9th (Nasopharynx)TNM 9th Ed (NSCLC)TNM 9th Ed (SCLC)Tyrer-Cuzick (IBIS v8)WHO 2021 CNS Class.WHO 2022 / ICC 2022 AMLZ0011 Eligibility

TNM 8th Ed (Prognostic)

Breast Cancer

Interpreter for integrated breast prognostic stage after combining anatomy and biomarkers.

Calculated Interpretation

Stage 0

Breast prognostic staging should integrate anatomic TNM with grade and receptor biology.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

Primary Use

  • Interpreter for integrated breast prognostic stage after combining anatomy and biomarkers.
CLINICAL INSIGHT

How it Works

Clinical Inputs

Integrated prognostic stage
CLINICAL INSIGHT

Practical Pearls

Result Bands

CLINICAL INSIGHT

Next Steps

Suggested Next Steps

  • Interpret the result in the full disease-specific clinical context.
  • Correlate with pathology, imaging, performance status, and multidisciplinary guidance.
CLINICAL INSIGHT

Evidence Base

Evidence Base

Interpreter for integrated breast prognostic stage after combining anatomy and biomarkers.

OpiCalc Medical Oncology ModuleBreast Cancer2026
CLINICAL INSIGHT

Background

Context

TNM 8th Ed (Prognostic) is included in the oncology module as a structured decision-support tool for breast cancer workflows.

No clinical reference data available.